Unguided Sacroiliac Injection: Effect on Refractory Buttock Pain in Patients With Spondyloarthropathies
NCT00829543 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2009-02-03
Summary
This study is designed to evaluate the efficacy and safety of guide-free sacroiliac joint (SIJ) injection in refractory sacroiliac pain due to spondyloarthropathies.
Conditions
- Spondylarthropathy
Interventions
- PROCEDURE
-
guide-free sacroiliac corticosteroid injection
guide-free sacroiliac injection of triamcinolone acetonide 40 mg in each sacroiliac joint
Sponsors & Collaborators
-
Tabriz University
lead OTHER
Principal Investigators
-
Shahram Sadreddini, Rheumatology · Tabriz medical university (Rheumatology Department)
-
Shahram Sadreddini, Rheumatology · Assistant professor of Tabriz medical university
-
Mahshid Molaeefard, MD · Tehran medical university
-
Seyed-Kazem Shakouri, Physiatrist · Assistant professor of Tabriz medical university
-
Morteza Ghojazadeh, Physiologist · Assistant professor of Tabriz medical university
-
Hamid Noshad, Nephrologist · Assistant professor of Tabriz medical university
-
Mohammad-Reza Ardalan, Nephrologist · Assistant professor of Tabriz medical university
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-09-30
- Primary Completion
- 2007-01-31
- Completion
- 2009-02-28
Countries
- Iran
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis
NCT05324631 ·Status: UNKNOWN ·Phase: PHASE3
-
Italian Registry of Arthritis on Biologic Therapy
NCT01543594 ·Status: RECRUITING
-
Monoarticular Corticosteroid Injection Versus Systemic Administration in the Treatment of Rheumatoid Arthritis Patients
NCT00506896 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis
NCT06860750 ·Status: RECRUITING ·Phase: PHASE3
-
Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis
NCT05055934 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
NCT02267642 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients
NCT02089087 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis
NCT06197009 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis
NCT04840485 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Usability of an AI for M923 in Subjects With Moderate to Severe RA
NCT02722044 ·Status: COMPLETED ·Phase: PHASE3
-
Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With Biotherapy
NCT04899154 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety Study of SUNPG1622
NCT02980705 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of the Handling Experience With the BI 695501 Autoinjector in Patients With Rheumatoid Arthritis Followed by an Extension Phase Using BI 695501 Prefilled Syringe
NCT02636907 ·Status: COMPLETED ·Phase: PHASE2
-
Characterizing Spondyloarthritis With 68Ga-FAPI PET/CT
NCT05999643 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid Arthritis
NCT01853033 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Mobile Application on Subcutaneous Anti-TNF Drug Administration:Ankylosing Spondylitis Patients
NCT04301128 ·Status: COMPLETED ·Phase: NA
-
A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector
NCT00643526 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population
NCT01361542 ·Status: COMPLETED ·Phase: NA
-
to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis
NCT05162937 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After Subcutaneous (SC) Administration to Subjects With Rheumatoid Arthritis (RA)
NCT00254293 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
NCT04795141 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
NCT07233655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
NCT00426218 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life
NCT02354105 ·Status: COMPLETED
-
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
NCT02456363 ·Status: UNKNOWN ·Phase: PHASE2